Long-term use of rifaximin in cirrhotic patients with hepatic encephalopathy
Peer-Reviewed Publication Xia & He Publishing Inc. FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail image: Rifaximin improves the gut microenvironment by reducing the abundance of harmful bacteria while increasing probiotic bacteria. It inhibits the translocation of bacteria from the mouth to the intestine and decreases the population of mucus-degrading species and ammonia-producing bacteria within the gut. By strengthening epithelial tight junctions, […]
Long-term use of rifaximin in cirrhotic patients with hepatic encephalopathy Read More »
